Lightnews — Scholar-powered news

NOTRELOAD AI @notreload.bsky.social · 1d

Today we are pleased to announce our first funding round of $750,000 to develop Algo Tier, the first AI agent focused on predictive market monitoring. This will enable us to deliver increasingly powerful tools for the 10,000 people who use NOTRELOAD AI every week. notreload.xyz/elevator-pit...

Invest in NOTRELOAD | Democratizing Market Intelligence

NOTRELOAD is raising $750K to scale AI-powered market intelligence from $400K to $3.2M ARR. Serving 15M retail traders with 20:1+ LTV:CAC.

notreload.xyz

NOTRELOAD AI @notreload.bsky.social · 1d

$HOLX [Blackstone and TPG are in advanced talks to acquire medical device maker Hologic for over $17 billion, potentially becoming one of 2025's largest private equity deals.] notreload.xyz/blackstone-t...

Blackstone, TPG in Talks for $17B Hologic Acquisition Deal

Blackstone and TPG are in advanced talks to acquire medical device maker Hologic for over $17 billion, potentially becoming one of 2025's largest private equity deals.

notreload.xyz

NOTRELOAD AI @notreload.bsky.social · 2d

BREAKING: The Federal Aviation Administration says $BA can increase its monthly production of the 737 Max to 42 planes, up from 38.

NOTRELOAD AI @notreload.bsky.social · 2d

U.S. stocks ended the week higher on Friday, with the S&P 500, Dow, and Nasdaq all scoring weekly gains as concerns about bank credit and China trade tensions eased.

NOTRELOAD AI @notreload.bsky.social · 2d

$CCO +18.7% [Mubadala Capital explores acquisition of Clear Channel Outdoor Holdings as outdoor advertising deals heat up globally.] notreload.xyz/abu-dhabi-mu...

Abu Dhabi's Mubadala Eyes Clear Channel Outdoor Acquisition

Mubadala Capital explores acquisition of Clear Channel Outdoor Holdings as outdoor advertising deals heat up globally. Stock jumps 19% on takeover speculation.

notreload.xyz

1

NOTRELOAD AI @notreload.bsky.social · 2d

$VRDN +4.8% [Jefferies and Wedbush maintain Buy ratings on Viridian Therapeutics as Roche's thyroid eye disease drug shows weaker results than Viridian's veligrotug therapy.] notreload.xyz/viridian-the...

Viridian Therapeutics Gets Buy Ratings After Roche Fails

Jefferies and Wedbush maintain Buy ratings on Viridian Therapeutics as Roche's thyroid eye disease drug shows weaker results than Viridian's veligrotug therapy.

notreload.xyz

NOTRELOAD AI @notreload.bsky.social · 2d

BREAKING: The Betaville blog, which focuses on M&As, sent an alert to its subscribers regarding a rumor about $NKTR

NOTRELOAD AI @notreload.bsky.social · 2d

$ATAI +6.6% [Jefferies raises Atai Life Sciences price target to $10 following FDA Breakthrough Therapy Designation for depression drug BPL-003, citing 72% approval rate for BTD drugs.] notreload.xyz/jefferies-ra...

Jefferies Raises Atai Life Sciences Price Target to $10 on FDA Breakthrough

Jefferies raises Atai Life Sciences price target to $10 following FDA Breakthrough Therapy Designation for depression drug BPL-003, citing 72% approval rate for BTD drugs.

notreload.xyz

NOTRELOAD AI @notreload.bsky.social · 2d

$VHC +39% [VirnetX, a cybersecurity firm, won a GSA contract making it an approved tech provider for government agencies.] ir.virnetx.com/news-release...

NOTRELOAD AI @notreload.bsky.social · 2d

$ACCL +10% [Acco opens at $4.05, IPO priced at $4 per share.]

NOTRELOAD AI @notreload.bsky.social · 2d

Dow, S&P 500 and Nasdaq all positive as investors move past banks' credit losses

NOTRELOAD AI @notreload.bsky.social · 2d

Gold, silver and platinum retreat as investors hit pause on metals rally

NOTRELOAD AI @notreload.bsky.social · 2d

$ORCL -7.5% [Investors worry about huge spending needs for AI infrastructure with OpenAI/Meta. Despite analyst upgrades, concerns over cash burn and financing dampened optimism—unusual since AI spending usually excites markets.]

NOTRELOAD AI @notreload.bsky.social · 3d

$ORCL +3.85% [Oracle shares spike 4% after revealing 30-40% margins on AI infrastructure deals with OpenAI, Meta, and xAI. Company expects cloud revenue to hit $166B by 2030.] notreload.xyz/oracle-surge...

Oracle Surges After Disclosing AI Data Center Profitability

Oracle shares spike 4% after revealing 30-40% margins on AI infrastructure deals with OpenAI, Meta, and xAI. Company expects cloud revenue to hit $166B by 2030.

notreload.xyz

NOTRELOAD AI @notreload.bsky.social · 2d

$GM +2.3%, $F +1.55%, $STLA +2%, $TSLA +2.3% ... [The White House will extend tariff relief for US carmakers by five years, helping Ford, GM, and others reduce costs from Trump's import duties on auto parts and vehicles.] notreload.xyz/white-house-...

White House Extends Auto Tariff Relief for US Carmakers

The White House will extend tariff relief for US carmakers by five years, helping Ford, GM, and others reduce costs from Trump's import duties on auto parts and vehicles.

notreload.xyz

NOTRELOAD AI @notreload.bsky.social · 2d

BREAKING: According to SemiAccurate, $INTC has a "large AI client" for the 18A/AP process.

NOTRELOAD AI @notreload.bsky.social · 2d

$APPF $BSY $BXP $CMC $DE $FCX $LUNR $IP $INVH $JEF $MMC $MCO $PNFP $ZION $OEC $ASTS $OZK $BAH $BRAG $GPK $KZR $KRC $RGA $SLGN $SMA $SON $SO $UDR $EQNR -- THE WSJ

NOTRELOAD AI @notreload.bsky.social · 2d

$LTH $MODG $PLNT $XPOF $ASND $BP $CBRL $CRDO $DK $XOM $DINO $IBIO $IVT $KTB $MPC $OXY $PSX $PRMB $SHEL $SU $VLO $VSEC $PECO -- THE WSJ

NOTRELOAD AI @notreload.bsky.social · 2d

Dow opens higher, erasing steep overnight drop on Trump China trade comments; gold climbs, cryptos under pressure

NOTRELOAD AI @notreload.bsky.social · 2d

$PLX -32% [Chiesi and Protalix received a negative CHMP opinion for Elfabrio's dosing regimen. The companies remain committed to reducing the treatment burden for Fabry disease patients.] notreload.xyz/ema-rejects-...

EMA Rejects Extended Dosing for Fabry Disease Treatment

Chiesi and Protalix received a negative CHMP opinion for Elfabrio's dosing regimen. The companies remain committed to reducing the treatment burden for Fabry disease patients.

notreload.xyz

NOTRELOAD AI @notreload.bsky.social · 2d

$KO flat [Coca-Cola is considering a $1B IPO of its Indian bottling business next year, potentially valuing it at $10B. This follows other global brands like LG & Hyundai listing in India's booming market. The move comes as Coke faces growing competition from Ambani's budget Campa Cola.]

Coca-Cola Weighs $1 Billion IPO of Indian Bottling Unit

Coca-Cola Co. is considering taking its Indian bottling unit public in a deal that may fetch $1 billion, according to people familiar with the matter.

www.bloomberg.com

NOTRELOAD AI @notreload.bsky.social · 2d

$JEF +5.7% [Oppenheimer upgraded Jefferies Financial to Outperform from Perform, setting an $81 price target.

"Jefferies' investor day brought increased confidence in its longer-term trajectory. The company has a specific issue with its First Brands exposure, but this is very limited."]

Loan Fraud and 'Cockroach' Concerns Slam Regional Bank Stocks as Credit Cracks Emerge

Shares of Zions Bancorp and Western Alliance tumbled after disclosing loan fraud tied to distressed commercial mortgages. This adds to wider concerns about asset quality, following bankruptcies like T...

notreload.xyz

NOTRELOAD AI @notreload.bsky.social · 2d

$AXP +1.55% [American Express exceeds Q3 expectations with $421B in transactions as new $895 Platinum card doubles account acquisitions, proving premium credit card demand remains strong.] notreload.xyz/american-exp...

American Express Q3 Earnings Surge on Platinum Card Demand

American Express exceeds Q3 expectations with $421B in transactions as new $895 Platinum card doubles account acquisitions, proving premium credit card demand remains strong.

notreload.xyz

NOTRELOAD AI @notreload.bsky.social · 2d

$ARTV +105.8% [Wedbush upgrades Artiva Biotherapeutics price target to $23 citing FDA Fast Track for AlloNK therapy targeting refractory rheumatoid arthritis with potential 2026 pivotal trial.] notreload.xyz/artiva-stock...

Artiva Stock Upgraded: Wedbush Raises Target to $23 on FDA Win

Wedbush upgrades Artiva Biotherapeutics price target to $23 citing FDA Fast Track for AlloNK therapy targeting refractory rheumatoid arthritis with potential 2026 pivotal trial.

notreload.xyz

NOTRELOAD AI @notreload.bsky.social · 2d

$ACHV +20.45% [Achieve Life Sciences receives FDA's National Priority Voucher for cytisinicline, potentially the first approved treatment to help people quit vaping and e-cigarettes.] notreload.xyz/fda-fast-tra...

FDA Fast-Tracks First Vaping Cessation Treatment | Cytisinicline Gets Priority Voucher

Achieve Life Sciences receives FDA's National Priority Voucher for cytisinicline, potentially the first approved treatment to help people quit vaping and e-cigarettes.

notreload.xyz

1

NOTRELOAD AI @notreload.bsky.social · 2d

$RVMD +7% [Revolution Medicines awarded FDA National Priority Voucher for daraxonrasib (RMC-6236), a breakthrough RAS inhibitor targeting pancreatic and lung cancer in Phase 3 trials.] notreload.xyz/revolution-m...

Revolution Medicines Receives FDA Priority Voucher for Cancer Drug Daraxonrasib

Revolution Medicines awarded FDA National Priority Voucher for daraxonrasib (RMC-6236), a breakthrough RAS inhibitor targeting pancreatic and lung cancer in Phase 3 trials.

notreload.xyz